Clinical Trial Update: Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women [Phase 3]

View source ↗

Summary

This document describes a Phase 3 clinical trial evaluating whether adding cisplatin to adjuvant chemotherapy improves outcomes for women with early-stage high-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Invasive Ductal Carcinoma of the Breast
• Mucinous Breast Cancer
• Tubular Breast Cancer

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: RenJi Hospital | Conditions: Tubular Breast Cancer, Mucinous Breast Cancer | Phase 3 | Status: RECRUITING